ArticleCancer medicine2025

Transcutaneous Imiquimod Combined With Anti-Programmed Cell Death-1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma.

Takashi Karashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.